Managing Cardiovascular Risk in Lysosomal Acid Lipase Deficiency
- 14 February 2017
- journal article
- review article
- Published by Springer Nature in American Journal of Cardiovascular Drugs
- Vol. 17 (3) , 217-231
Abstract
Lysosomal acid lipase deficiency (LAL-D) is a rare, life-threatening, autosomal recessive, lysosomal storage disease caused by mutations in the LIPA gene, which encodes for lysosomal acid lipase (LAL). This enzyme is necessary for the hydrolysis of cholesteryl ester and triglyceride in lysosomes. Deficient LAL activity causes accumulation of these lipids in lysosomes and a marked decrease in the cytoplasmic free cholesterol concentration, leading to dysfunctional cholesterol homeostasis. The accumulation of neutral lipid occurs predominantly in liver, spleen, and macrophages throughout the body, and the aberrant cholesterol homeostasis causes a marked dyslipidemia. LAL-D is characterized by accelerated atherosclerotic cardiovascular disease (ASCVD) and hepatic microvesicular or mixed steatosis, leading to inflammation, fibrosis, cirrhosis and liver failure. LAL-D presents as a clinical continuum with two phenotypes: the infantile-onset phenotype, formally referred to as Wolman disease, and the later-onset phenotype, formerly referred to as cholesteryl ester storage disease. Infants with LAL-D present within the first few weeks of life with vomiting, diarrhea, hepatosplenomegaly, failure to thrive and rapid progression to liver failure and death by 6–12 months of age. Children and young adults with LAL-D generally present with marked dyslipidemia, hepatic enzyme elevation, hepatomegaly and mixed steatosis by liver biopsy. The average age of the initial signs and symptoms of the later-onset phenotype is about 5 years old. The typical dyslipidemia is a significantly elevated low-density lipoprotein cholesterol (LDL-C) concentration and a low high-density lipoprotein cholesterol (HDL-C) concentration, placing these individuals at heightened risk for premature ASCVD. Diagnosis of the later-onset phenotype of LAL-D requires a heightened awareness of the disease because the dyslipidemia and hepatic transaminase elevation combination are common and overlap with other metabolic disorders. LAL-D should be considered in the differential diagnosis of healthy weight children and young adults with unexplained hepatic transaminase elevation accompanied by an elevated LDL-C level (>160 mg/dL) and low HDL-C level (<35 mg/dL) that is not caused by monogenic and polygenic lipid disorders or secondary factors. Treatment of LAL-D with sebelipase alfa (LAL replacement enzyme) should be considered as the standard of treatment in all individuals diagnosed with LAL-D. Other ASCVD risk factors that may be present (hypertension, tobacco use, diabetes mellitus, etc.) should be managed appropriately, consistent with secondary prevention goals.Keywords
This publication has 85 references indexed in Scilit:
- Lysosomal Acid Lipase Deficiency Impairs Regulation of ABCA1 Gene and Formation of High Density Lipoproteins in Cholesteryl Ester Storage DiseaseJournal of Biological Chemistry, 2011
- Thiadiazole Carbamates: Potent Inhibitors of Lysosomal Acid Lipase and Potential Niemann−Pick Type C Disease TherapeuticsJournal of Medicinal Chemistry, 2010
- PCSK9: a convertase that coordinates LDL catabolismJournal of Lipid Research, 2009
- The Human Gene Mutation Database: 2008 updateGenome Medicine, 2009
- Wolman disease/cholesteryl ester storage disease: efficacy of plant-produced human lysosomal acid lipase in miceJournal of Lipid Research, 2008
- Plasma PCSK9 preferentially reduces liver LDL receptors in miceJournal of Lipid Research, 2008
- Treatment and liver transplantation for cholesterol ester storage diseaseThe Journal of Pediatrics, 1995
- Use of simvastatin plus cholestyramine in the treatment of lysosomal acid lipase deficiencyThe Journal of Pediatrics, 1991
- Lovastatin therapy for cholesterol ester storage disease in two sistersThe Journal of Pediatrics, 1991
- Cholesterol ester storage disease: Clinical, biochemical, and pathological studiesThe Journal of Pediatrics, 1977